Production and Characterization of a SARS-CoV-2 Nucleocapsid Protein Reference Material.
Ontology highlight
ABSTRACT: Rapid antigen tests have become a widely used COVID-19 diagnostic tool with demand accelerating in response to the highly contagious SARS-CoV-2 Omicron variant. Hundreds of such test kits are approved for use worldwide, predominantly reporting on the presence of the viral nucleocapsid (N) protein, yet the comparability among manufacturers remains unclear and the need for reference standards is recognized. To address this lack of standardization, the National Research Council Canada has developed a SARS-CoV-2 nucleocapsid protein reference material solution, NCAP-1. Reference value determination for N protein content was realized by amino acid analysis (AAA) via double isotope dilution liquid chromatography-tandem mass spectrometry (LC-ID-MS/MS) following acid hydrolysis of the protein, in
SUBMITTER: Stocks BB
PROVIDER: S-EPMC9662649 | biostudies-literature | 2022 Dec
REPOSITORIES: biostudies-literature
ACCESS DATA